Health
Hungarian Biotech Motorpharma's Heart Attack Drug Candidate Published in Nature, Clinical Development Moves to Boston
A Hungarian-developed drug candidate has shown significant reduction of heart muscle damage in animal studies, with clin...
Noa Feldman
👁 3
💬 0
